Public disclosures

Carter Robert Ross

Company insiders · Chief Financial Officer · Starling Oncology, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-19.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Carter Robert Ross

Chief Financial Officer · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Other transaction
Filing details

SEC transaction code J

Common Stock · Direct ownership · Reported balance after transaction: 414663 · Reflects shares required to be sold pursuant to a sell-to-cover transaction in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units, mandated by the Issuer and does not reflect a discretionary trade by the Reporting Person.

2026-11-172026-11-19

138 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement